Shuttle Pharmaceuticals Holdings, Inc. Appoints Timothy Lorber as Chief Financial Officer
Company
Shuttle Pharmaceutical Holdings
GaithersburgInformation TechnologyBiotechnologySoftwareHealth CareArtificial IntelligenceMedicalPharmaceuticalinformation technology & servicesDescription
Shuttle Pharmaceuticals Holdings, Inc. announced the appointment of Timothy Lorber, CPA, as the Company Chief Financial Officer. The current CFO, Michael Vander Hoek, will transition to the full-time Vice President, Regulatory.
Quick answer
Shuttle Pharmaceuticals Holdings, Inc. Appoints Timothy Lorber as Chief Financial Officer (June 18, 2024). Shuttle Pharmaceutical Holdings is based in Gaithersburg, Maryland, United States.
- What did Shuttle Pharmaceutical Holdings announce on June 18, 2024?
- Shuttle Pharmaceuticals Holdings, Inc. announced the appointment of Timothy Lorber, CPA, as the Company Chief Financial Officer. The current CFO, Michael Vander Hoek, will transition to the full-time Vice President, Regulatory.
- What does Shuttle Pharmaceutical Holdings do?
- Shuttle owns a pharmaceutical software AI driven platform for molecular discovery and early-stage drug development.
- Where is Shuttle Pharmaceutical Holdings based?
- Shuttle Pharmaceutical Holdings is based in Gaithersburg, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- Odysight.ai (May 6, 2024), Lupin (June 17, 2024), Autonomize (June 24, 2024) and Exscientia (June 6, 2024) also announced leadership changes within 45 days of Shuttle Pharmaceutical Holdings.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Odysightai Appoints Einav Brenner as Chief Financial Officer (May 6, 2024)
- Abdelaziz Toumi Appointed as Chief Executive Officer of Lupin Manufacturing Solutions (LMS) (June 17, 2024)
- Autonomize AI Appoints Laksh Krishnamurthy as Vice President of Engineering and Achieves SOC2 Type 2 Certification (June 24, 2024)
- Exscientia Appoints John P. Overington as Chief Technology Officer and Marie-Louise Fjällskog, M.D., Ph.D., as Interim Chief Medical Officer (June 6, 2024)
- Eli Lilly and Company Appoints Melissa Seymour as Executive Vice President of Global Quality (June 4, 2024)
- Body Vision Medical Names Matt Baker as Chief Executive Officer (July 2, 2024)
Who to call at Shuttle Pharmaceutical Holdings, and when
A new leader at Shuttle Pharmaceutical Holdings brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Shuttle Pharmaceutical Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Shuttle Pharmaceutical Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Shuttle Pharmaceutical Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Shuttle Pharmaceutical Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Shuttle Pharmaceutical Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.